Your browser doesn't support javascript.
loading
Lovastatin Treatment of a Patient with a De Novo SYNGAP1 Protein Truncating Variant.
Cook, Edwin H; Masaki, Jayson T; Guter, Stephen J; Najjar, Fedra.
Affiliation
  • Cook EH; 1 Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, Chicago, Illinois.
  • Masaki JT; 1 Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, Chicago, Illinois.
  • Guter SJ; 1 Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, Chicago, Illinois.
  • Najjar F; 1 Department of Psychiatry, Institute for Juvenile Research, University of Illinois at Chicago, Chicago, Illinois.
J Child Adolesc Psychopharmacol ; 29(4): 321-322, 2019 05.
Article in En | MEDLINE | ID: mdl-30901256

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lovastatin / Ras GTPase-Activating Proteins / Autism Spectrum Disorder Limits: Adult / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2019 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lovastatin / Ras GTPase-Activating Proteins / Autism Spectrum Disorder Limits: Adult / Humans / Male Language: En Journal: J Child Adolesc Psychopharmacol Journal subject: PEDIATRIA / PSICOFARMACOLOGIA Year: 2019 Document type: Article Country of publication: United States